Zebra Medical Vision said on Monday it received approval from the U.S. Food and Drug Administration for its artificial intelligence-based chest X-ray triage product.
Read More
aMoon Fund leads round into developer of first ever clinically deployed AI Based Cancer Diagnosis system
Read More
Nerivio Migra, the Netanya-based company’s novel remote neuromodulation device for acute treatment of migraine, is under review by the FDA.
Read More
Israel-based healthcare fund aMoon II said on Wednesday it has received commitments of $660 million from investors. This is up from $600 million reported in January in an investor document obtained by Reuters.
Read More
One of Israel’s single largest venture capital funds is a new later stage vehicle focused on healthcare.
Read More
Results support the clinical development of AL101 as a targeted monotherapy for people with tumors bearing Notch activated mutations
Read More
Advances Phase 2 Study in Alzheimer’s Disease in Canada, RPh201 development in US supported by Fast Track Designation by US Food and Drug Administration
Read More
With product initially aimed for dental industry, Petah-Tikva based Nobio raises $3.6 million from aMoon Fund and Dr. Ole Jensen, a US surgeon and dentist
Read More
Zebra Medical Vision, an Israeli medical imaging startup that uses machine and deep learning to build tools for radiologists, has raised a $30 million Series C led by health technology fund aMoon Ventures, with participation from Aurum, Johnson & Johnson Innovation—JJDC Inc.
Read More
A new clinical validation study, published in the Journal of Clinical Oncology CCI, found that Medial EarlySign’s artificial intelligence tool flagged about 8 percent of patients in a large trial group that were later diagnosed with cancer or precancerous lesions.
Read More
Ibex’s Galen™ Prostate solution demonstrates outstanding results in a blinded study and supports pathologists in providing accurate diagnosis, enhanced lab efficiency and quality control.
Read More
While the new money may have been raised under the looming threat of Covid 19, the company’s technology is already being used to test for infection-causing pathogens in immunocompromised pediatric patients, and for potential causes of complex pneumonia, fungal infections and endocarditis, according to a statement from the company.
Read More
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire.
Read More
Israel-based life sciences, healthcare, and technology venture capital firm aMoon, together with an unnamed private investor, invested $5 million in cancer drug startup NanoGhosts, aMoon told Calcalist. This is NanoGhosts’s first investment.
Read More
Capital will enable continued advancement of novel Proteograph™ platform and commercialization of first-in-class proteomics products
Read More
The new entity, Vocalis Health, will develop technology for the voice-based analysis and detection of health issues such as heart and respiratory conditions and depression
Read More
The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.
Read More
Based on technology developed by the Technion’s Prof. Yoram Reiter, Adicet Bio is developing allogeneic cell therapies for cancer using innovative gamma delta T cells.
Read More
aMoon Leads New Investment Round with Participation from OrbiMed and Lightspeed Venture Partners.
Read More
Tel Aviv – has “the highest number of startups per capita in the world…with more than 6,000, of which 18 are unicorns…more than 100 venture capital funds, plus hundreds of accelerators and co-working places.”
Read More